• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利：CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法，用中文像聊天一样搜索，搜遍4000万医学文献。AI智能推荐，让科研检索更轻松。

立即免费搜索

文件翻译

保留排版，准确专业，支持PDF/Word/PPT等文件格式，支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述，25分钟生成高质量综述，智能提取关键信息，辅助科研写作。

立即免费体验

Immunologic Features in Coronavirus Disease 2019: Functional Exhaustion of T Cells and Cytokine Storm.

作者信息

Mahmoudi Shima, Rezaei Mitra, Mansouri Nahal, Marjani Majid, Mansouri Davood

机构信息

Pediatric Infectious Disease Research Center, Tehran University of Medical Sciences, Tehran, Iran.

Virology Research Center, National Research Institute of Tuberculosis and Lung diseases (NRITLD), Shahid Beheshti University of Medical Sciences, Tehran, Iran.

出版信息

J Clin Immunol. 2020 Oct;40(7):974-976. doi: 10.1007/s10875-020-00824-4. Epub 2020 Jul 10.

DOI:10.1007/s10875-020-00824-4
PMID:32648027
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC7347401/
Abstract
摘要
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/bbe4/7347401/e250c99dac0a/10875_2020_824_Fig1_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/bbe4/7347401/e250c99dac0a/10875_2020_824_Fig1_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/bbe4/7347401/e250c99dac0a/10875_2020_824_Fig1_HTML.jpg

相似文献

1
Immunologic Features in Coronavirus Disease 2019: Functional Exhaustion of T Cells and Cytokine Storm.2019年冠状病毒病的免疫学特征：T细胞功能耗竭与细胞因子风暴
J Clin Immunol. 2020 Oct;40(7):974-976. doi: 10.1007/s10875-020-00824-4. Epub 2020 Jul 10.
2
Cellular immune responses to covid-19.对新冠病毒的细胞免疫反应。
BMJ. 2020 Jul 31;370:m3018. doi: 10.1136/bmj.m3018.
3
Extracorporeal Hemoadsorption: An Option for COVID-19-Associated Cytokine Storm Syndrome.体外血液吸附：治疗新型冠状病毒肺炎相关细胞因子风暴综合征的一种选择
Shock. 2020 Nov;54(5):700-701. doi: 10.1097/SHK.0000000000001568.
4
Targeting T-cell senescence and cytokine storm with rapamycin to prevent severe progression in COVID-19.用雷帕霉素靶向T细胞衰老和细胞因子风暴以预防COVID-19的严重进展。
Clin Immunol. 2020 Jul;216:108464. doi: 10.1016/j.clim.2020.108464. Epub 2020 May 13.
5
COVID-19 in Africa: Dampening the storm?非洲的新冠疫情：平息风暴？
Science. 2020 Aug 7;369(6504):624-626. doi: 10.1126/science.abd3902.
6
Sepsis-associated severe interleukin-6 storm in critical coronavirus disease 2019.2019冠状病毒病危重症患者中与脓毒症相关的严重白细胞介素-6风暴
Cell Mol Immunol. 2020 Oct;17(10):1092-1094. doi: 10.1038/s41423-020-00522-6. Epub 2020 Sep 11.
7
A plea for the pathogenic role of immune complexes in severe Covid-19.关于免疫复合物在重症新型冠状病毒肺炎中致病作用的呼吁。
Clin Immunol. 2020 Aug;217:108493. doi: 10.1016/j.clim.2020.108493. Epub 2020 Jun 8.
8
Optimizing Administration of CAR T-Cell Therapy During the COVID-19 Pandemic.在2019冠状病毒病大流行期间优化嵌合抗原受体T细胞疗法的给药
Clin Adv Hematol Oncol. 2020 Jul;18(7):400-403.
9
Defining the Cytokine Storm Syndrome of COVID-19: Role of the Clinical Laboratory.定义COVID-19的细胞因子风暴综合征：临床实验室的作用。
Ann Clin Lab Sci. 2020 Sep;50(5):703-705.
10
The dynamic changes in cytokine responses in COVID-19: a snapshot of the current state of knowledge.新型冠状病毒肺炎中细胞因子反应的动态变化：当前知识现状概述
Nat Immunol. 2020 Oct;21(10):1146-1151. doi: 10.1038/s41590-020-0779-1.

引用本文的文献

1
Histopathological examination of lung from infant with lethal COVID-19 with special attention on pneumocytes type II and the immune infiltrate: a case study.对患有致命性新冠病毒病的婴儿肺部进行组织病理学检查，特别关注II型肺细胞和免疫浸润：一项病例研究。
Ital J Pediatr. 2025 Jun 7;51(1):174. doi: 10.1186/s13052-025-01984-y.
2
Pathophysiology of Disseminated Intravascular Coagulation in Sepsis: A Clinically Focused Overview.脓毒症弥散性血管内凝血的病理生理学：临床重点概述。
Cells. 2023 Aug 22;12(17):2120. doi: 10.3390/cells12172120.
3
Flow cytometry profiling of cellular immune response in COVID-19 infected, recovered and vaccinated individuals.

本文引用的文献

1
Interleukin-6 in Covid-19: A systematic review and meta-analysis.白细胞介素 6 在新冠病毒感染中的作用：系统评价和荟萃分析。
Rev Med Virol. 2020 Nov;30(6):1-9. doi: 10.1002/rmv.2141. Epub 2020 Aug 26.
2
Impaired type I interferon activity and inflammatory responses in severe COVID-19 patients.严重 COVID-19 患者的 I 型干扰素活性和炎症反应受损。
Science. 2020 Aug 7;369(6504):718-724. doi: 10.1126/science.abc6027. Epub 2020 Jul 13.
3
Reduction and Functional Exhaustion of T Cells in Patients With Coronavirus Disease 2019 (COVID-19).
流式细胞术分析 COVID-19 感染者、康复者和接种者的细胞免疫反应。
Immunobiology. 2023 May;228(3):152392. doi: 10.1016/j.imbio.2023.152392. Epub 2023 May 8.
4
Evaluation of Lymphocyte Subtypes in COVID-19 Patients.新冠病毒肺炎患者淋巴细胞亚群的评估
Tanaffos. 2022 Mar;21(3):293-301.
5
Association of Mortality with Lymphocyte Subset in Patients with COVID-19-associated Acute Respiratory Failure: A Subgroup Analysis.新型冠状病毒肺炎相关急性呼吸衰竭患者死亡率与淋巴细胞亚群的关联：一项亚组分析
Indian J Crit Care Med. 2023 Jan;27(1):52-56. doi: 10.5005/jp-journals-10071-24392.
6
The role of angiotensin I converting enzyme insertion/deletion polymorphism in the severity and outcomes of COVID-19 patients.血管紧张素I转换酶插入/缺失多态性在COVID-19患者严重程度及预后中的作用
Front Genet. 2022 Nov 29;13:1035796. doi: 10.3389/fgene.2022.1035796. eCollection 2022.
7
Dysfunctional phenotype of systemic and pulmonary regulatory T cells associate with lethal COVID-19 cases.系统性和肺部调节性 T 细胞的功能障碍表型与致死性 COVID-19 病例相关。
Immunology. 2023 Apr;168(4):684-696. doi: 10.1111/imm.13603. Epub 2022 Nov 23.
8
Efficacy and safety of polyherbal formulation as an add-on to standard-of-care in mild-to-moderate COVID-19: A randomized, double-blind, placebo-controlled trial.多草药配方作为轻至中度新冠肺炎标准治疗附加疗法的疗效与安全性：一项随机、双盲、安慰剂对照试验
J Ayurveda Integr Med. 2022 Oct-Dec;13(4):100653. doi: 10.1016/j.jaim.2022.100653. Epub 2022 Oct 24.
9
Multisystem inflammatory syndrome associated with SARS-CoV-2 infection in children: update and new insights from the second report of an Iranian referral hospital.儿童感染严重急性呼吸综合征冠状病毒 2 相关多系统炎症综合征：伊朗转诊医院第二次报告的最新信息和新见解。
Epidemiol Infect. 2022 Oct 18;150:e179. doi: 10.1017/S0950268822001522.
10
Prognostic impacts of soluble immune checkpoint regulators and cytokines in patients with SARS-CoV-2 infection.可溶性免疫检查点调节剂和细胞因子对 SARS-CoV-2 感染患者预后的影响。
Front Immunol. 2022 Aug 15;13:903419. doi: 10.3389/fimmu.2022.903419. eCollection 2022.
新型冠状病毒病（COVID-19）患者 T 细胞减少和功能耗竭。
Front Immunol. 2020 May 1;11:827. doi: 10.3389/fimmu.2020.00827. eCollection 2020.
4
COVID-19 cytokine storm: the interplay between inflammation and coagulation.新型冠状病毒肺炎细胞因子风暴：炎症与凝血之间的相互作用
Lancet Respir Med. 2020 Jun;8(6):e46-e47. doi: 10.1016/S2213-2600(20)30216-2. Epub 2020 Apr 27.
5
Complex Immune Dysregulation in COVID-19 Patients with Severe Respiratory Failure.COVID-19 患者严重呼吸衰竭的复杂免疫失调。
Cell Host Microbe. 2020 Jun 10;27(6):992-1000.e3. doi: 10.1016/j.chom.2020.04.009. Epub 2020 Apr 21.
6
Neutrophil-to-lymphocyte ratio as an independent risk factor for mortality in hospitalized patients with COVID-19.中性粒细胞与淋巴细胞比值可作为 COVID-19 住院患者死亡的独立危险因素。
J Infect. 2020 Jul;81(1):e6-e12. doi: 10.1016/j.jinf.2020.04.002. Epub 2020 Apr 10.
7
The use of anti-inflammatory drugs in the treatment of people with severe coronavirus disease 2019 (COVID-19): The Perspectives of clinical immunologists from China.抗炎药物在治疗重症新型冠状病毒病 2019（COVID-19）患者中的应用：来自中国临床免疫学家的观点。
Clin Immunol. 2020 May;214:108393. doi: 10.1016/j.clim.2020.108393. Epub 2020 Mar 25.
8
COVID-19 infection: the perspectives on immune responses.新型冠状病毒肺炎感染：免疫反应的观点
Cell Death Differ. 2020 May;27(5):1451-1454. doi: 10.1038/s41418-020-0530-3. Epub 2020 Mar 23.
9
Functional exhaustion of antiviral lymphocytes in COVID-19 patients.新冠病毒肺炎患者抗病毒淋巴细胞的功能耗竭
Cell Mol Immunol. 2020 May;17(5):533-535. doi: 10.1038/s41423-020-0402-2. Epub 2020 Mar 19.
10
COVID-19: consider cytokine storm syndromes and immunosuppression.2019冠状病毒病：考虑细胞因子风暴综合征和免疫抑制。
Lancet. 2020 Mar 28;395(10229):1033-1034. doi: 10.1016/S0140-6736(20)30628-0. Epub 2020 Mar 16.